Carolina Molecular provides an integrated molecular testing platform that combines CLIA‑certified clinical assay development, scalable next‑generation sequencing services, and custom bioinformatics pipelines under a single contract. By partnering with leading technology providers, it delivers instrument‑free kinetic workflows for single‑cell RNA‑seq, high‑plex spatial profiling, and end‑to‑end data processing, helping CROs, biotech firms, and research institutions accelerate discovery and diagnostic projects with consistent, high‑quality results.
Funding
Funding not disclosed
Founders
Product
Problem
Researchers and developers in life sciences often face fragmented molecular testing services, requiring multiple vendors for clinical assays, next‑generation sequencing, and data analysis. This fragmentation leads to longer timelines, inconsistent data quality, and higher costs for projects that need integrated, regulatory‑compliant workflows.
Solution
Carolina Molecular offers a unified molecular testing platform that combines CLIA‑certified clinical assay development, scalable NGS foundry services, and custom bioinformatics pipelines under a single contract. By partnering with leading technology providers, the company delivers the latest sequencing chemistries, instrument‑free kinetic workflows for single‑cell RNA‑seq, and high‑plex spatial profiling (GeoMx, Molecular Pixelation). Clients receive end‑to‑end support—from sample receipt and library preparation to data processing and publication‑ready reports—enabling faster, more reliable results for discovery, translational, and diagnostic projects.
Target Audience
Primary customers are CROs, CDMOs, pharmaceutical and biotech companies, cell‑ and gene‑therapy innovators, and academic or industry research institutions that require comprehensive, regulated molecular testing and data analysis services.
Features
- CLIA‑certified and CAP‑accredited clinical testing workflows for diagnostic development
- Flexible, high‑throughput NGS foundry with access to the latest sequencing platforms and chemistries
- Instrument‑free kinetic workflows that generate scalable, high‑quality single‑cell RNA‑seq data for any sample type
- Digital spatial profiling (GeoMx) and 3‑D molecular pixelation for high‑plex RNA and protein quantification directly on tissue sections
- Custom bioinformatics pipelines that transform raw data into analysis‑ready, publication‑grade results
- Integrated sample storage and biospecimen management for CROs, CDMOs, and biotech partners